OR WAIT 15 SECS
LITTLE FALLS, N.J. -- Cantel Medical Corp., a provider of infection prevention and control products, today announced the appointment of R. Scott Jones as president and CEO of the company. Jones, who was selected following an extensive national search, is a veteran of the healthcare products and services industry. He most recently served as president and CEO of Symphony Health Services, Inc., a leading provider of contract healthcare services with more than 6,000 employees. Symphony Health Services was acquired by RehabCare Group Inc. in July 2006.
Prior to joining Symphony, Jones served as president and CEO of Accentia, Inc., an international specialty bio-pharmaceutical company, and as COO at PharMerica, Inc., a provider of pharmacy products and services for specialized patient populations in long-term care and alternate care facilities, which was acquired by AmerisourceBergen Corporation (formerly Bergen Brunswick Corp.).
Jones background also includes extensive experience with global medical product companies, including an eight-year tenure with General Electric Medical Systems, where he led the X-Ray Products group for North and South America and held an international assignment in Tokyo, Japan. He currently serves as a director for American Radiology Services, an affiliate of the Johns Hopkins University School of Medicine. Jones holds a masters degree in bioengineering from PennsylvaniaStateUniversity and a bachelors degree in biochemistry and biophysics from the State University of New York.
The Cantel Board conducted a comprehensive search for the strongest candidate to lead the next stage of our growth, said Charles Diker, chairman of the board. We are thrilled to bring Scott on board and believe his healthcare and acquisition experience will be a tremendous asset to the company. With the successful integration of our Crosstex acquisition, the continuing development of Mar Cor Purification, and Minntechs leadership position in dialysis and endoscope reprocessing, Scott is arriving at a critical stage of our development. We are confident in Scotts ability to grow our core infection prevention and control businesses and to help us expand through acquisitions and other growth opportunities.
Jones succeeds James P. Reilly, who is retiring after serving as president and CEO since 1989.
Cantel Medical Corp. is a leading provider of infection prevention and control products, including specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens.
Source: Cantel Medical Corp.